Comparing two types of shoulder injections for osteoarthritis pain relief
Official title: A Randomized Single-blinded Clinical Trial of the Efficacy of Intra-articular Infiltration of Cingal (Sodium Hyaluronate/Triamcinolone) Versus Cortisone (Triamcinolone) in Patients With Osteoarthritis of the Shoulder.
Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT05408065 · Data updated 2026-11-12
This study is testing whether a new shoulder injection called Cingal can help people with moderate to severe shoulder osteoarthritis feel less pain compared to a standard cortisone injection.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 84 (estimated) |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | November 15, 2022 |
| Main results expected | September 2026 |
| Study ends | December 2026 |
| Registry record updated | February 12, 2024 |
| Trial ID | NCT05408065 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 20 to 90 with moderate to severe primary shoulder osteoarthritis and a pain level of at least 4/10.
✕Probably not a fit
Patients with certain exclusions, such as those with a rotator cuff tear or who have had recent cortisone injections, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the analgesic effects of two different shoulder infiltrations: Cingal, which combines sodium hyaluronate and triamcinolone, and cortisone alone. It will involve 84 patients with moderate to severe shoulder osteoarthritis, who will be randomly assigned to receive one of the two treatments. The study will assess pain relief and functional ability through clinical examinations and patient questionnaires. The goal is to determine if Cingal provides greater pain relief than cortisone in this patient population.
Why it matters
Potential benefit: If successful, this study could offer a more effective pain management option for patients with shoulder osteoarthritis.
How similar studies have gone: While several studies have shown the effectiveness of hyaluronic acid for other joint conditions, the specific comparison of Cingal and cortisone for shoulder osteoarthritis is less explored, making this approach somewhat novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A clinical examination that confirms the radiological diagnosis of moderate to severe primary shoulder osteoarthritis, stage II and above, according to the Samilson-Prieto classification. * Patients aged between 20 and 90 years. * A patient with bilateral shoulder osteoarthritis will choose the side of the infiltration, only one side can be chosen to participate in the study. * The patient must have a clinical pain threshold of a minimum of 4/10 on the visual analogue scale. * The patient must have the cognitive ability to read and fill out the questionnaires. * The patient must be able to read and understand French or English Exclusion Criteria: * Presence of a transfixing rotator cuff tear assessed on MRI. * No previous shoulder reconstruction surgery. * Pregnant woman. * A patient who has received a cortisone infiltration within 6 months prior to the start of the study. * A patient who has received a platelet-rich plasma or a hyaluronic acid infiltration within 12 months prior to the start of the study. * Diagnosis of avascular necrosis. * Disease affecting the studied joint (systemic inflammatory disease, history of septic arthritis, osteonecrosis, etc.) * Suspicion or presence of active local infectious process. * Presence or suspicion of neoplasia or local metastasis. * Severe trauma to the shoulder ( ≤ 3 months) * Significant cognitive impairment or insufficient language proficiency to adequately answer the questionnaires. * Any other serious medical condition that does not allow participation in the study or may be a contraindication to cortisone injection.
Where it's running
-
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Patrice Tétreault, MD FRCSC — Chum
- Study coordinator: Fidaa Al-Shakfa, M.Sc, MBA
- Email: f.alshakfa.crchum@gmail.com
- Phone: 5148908000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Steroid injections into myofascial trigger points versus joint injections for shoulder osteoarthritis
This study will test whether steroid injections into muscle trigger points work as well as steroid injections into the shoulder joint for adults with shoulder osteoarthritis and ongoing shoulder pain.
-
Using a wearable device to manage work-related shoulder pain
This study is testing a wearable device that helps workers with shoulder pain by giving them feedback on their movements to see if it can make their pain and work limitations better.
-
Personalized mobile health app to aid recovery after reverse shoulder arthroplasty
A personalized mobile app is tested to see if tailored information and rehab guidance help people recover better after reverse shoulder arthroplasty compared with standard care.
-
Using CBD to manage pain after shoulder surgery
This study is testing if a CBD medication can help people manage pain better after shoulder surgery compared to a placebo.
-
Evaluating the AETOS Shoulder System for shoulder replacement surgeries
This study is testing the AETOS Shoulder System to see if it is safe and effective for people with shoulder arthritis who need shoulder replacement surgery.
-
Comparing two methods of shoulder joint replacement for stability
This study is testing whether a new metal-based shoulder replacement technique is just as stable as the traditional bone-based method for people with shoulder arthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.